Welcome to Dwaey, specifically on Hepatitis B Vaccine (rDNA) BP page.
This medicine contains important and useful components, as it consists of
Hepatitis B Vaccine (rDNA) BP is available in the market in concentration.
Hepatitis B Vaccine (rDNA) BP
Before receiving the Hepatitis B Vaccine (rDNA) BP, patients should consult with their healthcare provider to ensure the vaccine is suitable for them. Key precautions include:
- Allergy: Individuals with a known hypersensitivity or allergic reaction to any component of the vaccine, including yeast (as the vaccine is produced using recombinant DNA technology in Saccharomyces cerevisiae), should not receive this vaccine.
- Pregnancy: The Hepatitis B vaccine is categorized as Category C for pregnancy by the FDA, meaning there is no sufficient evidence of safety or harm. It should only be administered during pregnancy if absolutely necessary, and the benefits outweigh the risks. Pregnant women should discuss the vaccine with their healthcare provider.
- Breastfeeding: It is generally safe to administer the Hepatitis B Vaccine to breastfeeding mothers, but it is essential to consult a healthcare provider before use.
- Illness: For individuals suffering from moderate to severe illness (especially with fever), the vaccine should typically be deferred until recovery. Mild conditions like a common cold do not require postponement.
- Immunocompromised Patients: Individuals with weakened immune systems (due to diseases like HIV or treatments like chemotherapy or immunosuppressive medications) should consult their healthcare provider, as the immune response to the vaccine may be lower.
The Hepatitis B Vaccine (rDNA) BP is primarily used to prevent Hepatitis B infection, which is caused by the Hepatitis B virus (HBV). The indications include:
- Prevention of Hepatitis B Virus Infection: The vaccine is indicated for people at risk of acquiring Hepatitis B infection, including:
- Infants: The vaccine is administered as part of the routine childhood immunization schedule. It is typically given to infants at birth or during their first few months.
- Healthcare Workers: People who are regularly exposed to blood or bodily fluids (e.g., doctors, nurses, laboratory technicians) are at high risk for Hepatitis B infection and should be vaccinated.
- Infants Born to Infected Mothers: Newborns born to mothers who are HBV positive should receive the vaccine along with Hepatitis B immune globulin (HBIG) for protection against the virus.
- People with Multiple Sexual Partners: People engaging in unprotected sex or with multiple sexual partners are at higher risk of exposure and should be vaccinated.
- Injectable Drug Users: Those who inject drugs and share needles or other equipment are at higher risk and should be vaccinated.
- People with Chronic Liver Disease: Individuals suffering from liver conditions, such as cirrhosis, hepatitis C, or hepatitis D, should be vaccinated to reduce the risk of further liver damage.
- Travelers to Endemic Areas: People traveling to regions where Hepatitis B is highly prevalent (such as parts of Asia, Africa, and Eastern Europe) should receive the vaccine prior to travel.
The Hepatitis B Vaccine (rDNA) BP is contraindicated in the following situations:
- Severe Allergic Reaction: The vaccine should not be used in individuals who have had a severe allergic reaction (e.g., anaphylaxis) to a previous dose of the vaccine or to any of its components, particularly yeast.
- Severe Immunodeficiency: While generally safe for individuals with mild to moderate immunosuppression, the vaccine may be less effective in people with severe immunodeficiencies (e.g., agammaglobulinemia or severe combined immunodeficiency). These individuals should consult their healthcare provider before receiving the vaccine.
- Pregnancy (Caution): The Hepatitis B Vaccine is a Category C drug during pregnancy, so its administration should only be considered if the potential benefits outweigh the risks.
- Newborns of Infected Mothers: Newborns of mothers with Hepatitis B should receive both the vaccine and Hepatitis B immune globulin (HBIG) rather than just the vaccine alone.
Most individuals tolerate the Hepatitis B Vaccine (rDNA) BP well, but as with all vaccines, there are some potential side effects:
- Local Reactions: The most common side effects are pain, redness, or swelling at the injection site.
- Fever: A mild fever may occur after vaccination, usually lasting for a day or two.
- Fatigue or Irritability: Some individuals, particularly children, may experience general fatigue or irritability after receiving the vaccine.
- Headache: A mild headache is also commonly reported.
- Gastrointestinal Symptoms: Some people may experience nausea or vomiting.
- Allergic Reactions: Though rare, serious allergic reactions such as rash, difficulty breathing, swelling of the face or throat, or anaphylaxis may occur. These require immediate medical attention.
- Joint Pain: Some individuals may report muscle or joint pain, but this typically resolves on its own.
3
The Hepatitis B Vaccine (rDNA) BP works by stimulating the body's immune system to produce antibodies against the Hepatitis B virus (HBV), thus preventing future infections. The vaccine contains recombinant DNA-derived HBV surface antigens that do not cause infection but allow the body to "learn" to recognize the virus:
- Antigen Presentation: The Hepatitis B surface antigen (HBsAg) in the vaccine triggers the body to recognize the Hepatitis B virus as foreign.
- Immune Response: The immune system then produces antibodies that can specifically target and neutralize the virus if the individual is later exposed to HBV.
- Memory Cells: After vaccination, the immune system develops memory cells, which "remember" how to fight the virus, ensuring protection against future infection.
The Hepatitis B Vaccine (rDNA) BP may interact with certain other vaccines or medications:
- Other Vaccines: The Hepatitis B Vaccine can be given concurrently with other vaccines (e.g., Hepatitis A, MMR, DTP), usually at different injection sites. Co-administration does not interfere with the efficacy of any vaccine.
- Immunosuppressive Drugs: The effectiveness of the Hepatitis B vaccine may be reduced in individuals receiving immunosuppressive treatments (e.g., corticosteroids, chemotherapy, immunosuppressive therapy for organ transplant recipients).
- Blood or Immune Globulin Products: If a patient has recently received blood products, immune globulin, or hepatitis B immune globulin (HBIG), it may reduce the effectiveness of the vaccine. A waiting period is usually recommended before receiving the vaccine.
- Medications Affecting Immune Response: Medications that suppress the immune system, including drugs for autoimmune diseases, may reduce the immune response to the Hepatitis B Vaccine.
The standard adult dose for the Hepatitis B Vaccine (rDNA) BP is as follows:
- Initial Dose: A single dose of 1 ml (containing 10 mcg of recombinant Hepatitis B surface antigen) is administered intramuscularly (typically in the deltoid muscle of the upper arm).
- Booster Doses: The vaccine is typically administered in a three-dose series:
- First dose: Initial dose (Day 0)
- Second dose: After 1 month
- Third dose: After 6 months from the first dose
This three-dose series ensures long-term immunity against Hepatitis B.
For children, the Hepatitis B Vaccine (rDNA) BP is typically administered in a three-dose series:
- Infants and Children (0–19 years):
- Initial Dose: 1 ml (containing 10 mcg of Hepatitis B surface antigen) injected intramuscularly.
- Second Dose: Given at 1 month after the first dose.
- Third Dose: Given at 6 months after the first dose.
The vaccine is typically given at birth as part of the routine immunization schedule for infants.
---
In patients with renal impairment, there are typically no specific dosage adjustments for the Hepatitis B Vaccine (rDNA) BP. However, individuals with severe kidney disease or those undergoing hemodialysis should discuss the vaccine with their healthcare provider, as their immune response may be diminished.
Not available in a medicine form yet